UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000057416 |
|---|---|
| Receipt number | R000065571 |
| Scientific Title | Prospective Study on the Effectiveness of Skin Cancer Awareness Initiatives in Encouraging Early Medical Visits |
| Date of disclosure of the study information | 2025/03/26 |
| Last modified on | 2026/03/31 08:10:26 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Prospective Study on the Effectiveness of Skin Cancer Awareness Initiatives in Encouraging Early Medical Visits
Acronym
Skin Cancer Early Visit Study
Scientific Title
Prospective Study on the Effectiveness of Skin Cancer Awareness Initiatives in Encouraging Early Medical Visits
Scientific Title:Acronym
Skin Cancer Early Visit Study
Region
| Japan |
Condition
Condition
Skin Cancer
Classification by specialty
| Dermatology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
This study aims to evaluate the effectiveness of awareness campaigns designed to enhance motivation for medical consultation, with the goal of promoting early detection and treatment of skin cancer. Specifically, we will analyze changes in participants' motivation to seek medical attention before and after educational interventions, such as the distribution of informational pamphlets and public lectures, using questionnaire-based surveys. The findings are expected to identify effective strategies for public awareness, thereby facilitating timely consultation and diagnosis among a broader population.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Changes in motivation for medical consultation before and after the awareness campaign
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Behavior,custom |
Interventions/Control_1
The intervention consists of disease awareness activities, including pamphlet distribution, public lectures, and information dissemination through websites and media. These activities will be conducted from March 2025 to December 2026 as part of routine clinical practice at participating facilities. Patients may be exposed to the intervention during their visit. The frequency and number of activities vary by facility, but they will be implemented continuously within the study period.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients with skin tumors who visited or will visit the participating institution(s) between June 2024 and December 31, 2026, and responded to the questionnaire or are expected to respond
Key exclusion criteria
Patients who are mentally or physically unable to complete the questionnaire
Target sample size
3000
Research contact person
Name of lead principal investigator
| 1st name | Megumi |
| Middle name | |
| Last name | Aoki |
Organization
NHO Kagoshima Medical Center
Division name
Dermato-oncology
Zip code
892-0853
Address
8-1 Shiroyama-cho, Kagoshima City, Kagoshima Prefecture
TEL
099-223-1151
od65847@qb3.so-net.ne.jp
Public contact
Name of contact person
| 1st name | Megumi |
| Middle name | |
| Last name | Aoki |
Organization
NHO Kagoshima Medical Center
Division name
Dermato-oncology
Zip code
892-0853
Address
8-1 Shiroyama-cho, Kagoshima City, Kagoshima Prefecture
TEL
099-223-1151
Homepage URL
od65847@qb3.so-net.ne.jp
Sponsor or person
Institute
NHO Kagoshima Medical Center, Dermato-oncology
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
NHO Kagoshima Medical Center
Address
8-1 Shiroyama-cho, Kagoshima City, Kagoshima Prefecture
Tel
099-223-1151
od65847@qb3.so-net.ne.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 03 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 02 | Month | 17 | Day |
Date of IRB
| 2025 | Year | 03 | Month | 07 | Day |
Anticipated trial start date
| 2025 | Year | 03 | Month | 27 | Day |
Last follow-up date
| 2027 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 03 | Month | 26 | Day |
Last modified on
| 2026 | Year | 03 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065571
